Parasitology - PowerPoint PPT Presentation

1 / 70
About This Presentation
Title:

Parasitology

Description:

Parasitology Dr Hussien Bamashmous PROTOZOA OR METAZOA PROTOZOA Protos : first Zoon ... – PowerPoint PPT presentation

Number of Views:614
Avg rating:3.0/5.0
Slides: 71
Provided by: med05Coml
Category:

less

Transcript and Presenter's Notes

Title: Parasitology


1
Parasitology
  • Dr Hussien Bamashmous

2
PROTOZOAOR
  • METAZOA

3
  • PROTOZOA
  • Protos first
    Zoon animal
  • Phylum of animal kingdom which includes simplest
    animals
  • most are unicellular
  • some are colonial
  • REPROPDUCTION
  • usually asexual by fission
  • some sexual reproduction

4
  • EXAMPLES OF PROTOZOAL DISEASE
  • Malaria
  • Amebiasis
  • Giardiasis
  • Trichomoniasis
  • Toxoplasmosis
  • Visceral leishmaniasis
  • Pneumocystis carinii

5
  • METAZOA
  • META after / beyond ZOON animal
  • DIVISION OF THE ANIMAL KINGDOM THAT INCLUDES ALL
    MULTICELLULAR FORM
  • They are either
  • NEMATODES or CESTODES

6
1- NEMATODES
  • NEMA thread EIDOS form
  • Nematohelminthes are either
  • round, cylindrical, spindle shaped.
  • Examples
  • ENTEROBIASIS OXYURIASIS ( pin worm)
  • ASCARASIS round worm
  • ANCYLOSTOMIASIS hook worm
  • TRICHINOSIS
  • TRICHURIASIS whip worm

7
2- CESTODES
  • KESTOS GIRDLE
  • Subclass of Cestoidae ? phylum



  • PLATYHELMINTHES
  • EXAMPLES
  • TAENIASIS tapeworms scolex segments

  • (proglottidis)
  • VISCERAL LAVAR MIGRANS
  • FILARIASIS
  • BILHARSIASIS (schistosomiasis)

8
MALARIAmal - aria
9
MALARIA
  • ESSENTIALS OF DIAGNOSIS
  • Residence in or travel to an endemic area
  • High fever, chills, headache
  • Jaundice, vomiting, diarrhea
  • Anemia, splenomegally
  • Seizures, coma
  • Malaria parasite in the blood smear

10
  • GENERAL CONSIDERATIONS
  • Malaria kills 1,000,000 children/ year
  • Resurgence is observed now
  • Female Anopheline mosquito transmits the
    parasite
  • Plasmodium Vivax (most common)
  • P. Falciparum (most
    virulent)
  • P. Ovale
    (similar to Vivax)
  • P. Malariae

11
(No Transcript)
12
(No Transcript)
13
  • LIFE CYCLE
  • INFECTED HUMAN BLOOD (GAMETOCYTES)
  • Sucked by Anopheline mosquito
  • In its stomach wall
  • OOKINTE ? OOCYST ? MATURE OOCYST
  • ? rupture ? SPORPZOITE ?
  • to its salivary glands ? bite uninfected
    person
  • In the uninfected person Sporozoites disappear
    within
  • 1/2 hour from the circulation and infect the
    hepatocytes

14
  • HEPATIC PHASE ( PRE-ERYTHROCYTIC PHASE)
  • about 2 weeks for all
  • 3-5 weeks for P. Malarie
  • Hypnozoites ? ONLY FOR P.VIVAX AND OVALE which
    is responsible for future relapses.
  • Merozoites leave the liver thereafter to infect
    the RED BLOOD CELLS ERYTHROCYTIC CYCLE

15
  • ERYTHROCYTIC CYCLE (ASXETUAL CYCLE)
  • ERYTHROCYTE HAEMOLYSIS
  • METROZOITES ? TROPHOZOITES ?SCHIZONTS ?
    METROZOITES (which will be released by
    heamolysis)
  • SYMPTOMS
  • IMMATURE GAMETOCYTES
  • MATURE GAMETOCYTS (male female)
  • Sucked by mosquito
  • REPEAT THE CYCLE

16
(No Transcript)
17
  • P. VIVAX ? affects young red cells ? ruptures ?
    symptoms X 48 hours
  • P. MALARIAE ? old red cells ? symptoms X 72 hours
  • P. FALCIPARUM ? all cells ? NO CLASSICAL TRIAD OF
    SYMPTOMS
  • SURVIVAL (especially in endemic area)
  • ? immunity
  • ? intensity of the cycles

18
  • NO HEPATIC PHASE (pre- erythrocytic phase)
    with
  • Blood transfusion
  • Needle stick
  • Congenital malaria
  • Susceptibility varies genetically
  • Partial resistance to infection with
  • Hemoglobin S
  • Hemoglobin F
  • Thalassemia
  • G6PD deficiency
  • Maternal immunity protects the neonate despite
    placental infection
  • Clinical findings varies according to
  • strain
  • host immunity

19
PRESENTATION
  • CLASSICAL TRIAD WITH P. VIVAX P. OVALE
  • COLD STAGE
  • AFTER ½ HOUR ? HOT STAGE
  • AFTER 1-6 HOURS ? SWEATING

20
  • OTHER SYMPTOMS AND SIGNS
  • Pallor and irritability
  • Poor feeding
  • Vomiting and diarrhea
  • Jaundice
  • Splenomegally
  • Hepatomegally
  • OLDER CHILDREN
  • Headache and backache
  • Myalgia
  • Fatigue

21
  • IF UNTREATED RELAPSES STOPPED
  • Within a year with P. Falciparum
  • Within several years with P. Vivax
  • May occur decades later with P. Malariae
  • INFECTION DURING PREGNANCY
  • Intrauterine growth retardation
  • Preterm
  • Congenital malaria

22
  • LABORATORY FINDINGS
  • Multiple thick smears ? Giemsa stain
  • Thin smear ? Wright stain
  • In P. falciparum ? only ring form of Trophozoited
    Gametocytes are seen in peripheral smear.
  • GAMETOCYTES MAY PERSIST FOR DAYS FOLLOWING
    ADEQUATE THERAPY

23
  • Complete Blood Count
  • Normocytic normochromic anemia
  • Leucopenia, leucoytosis
  • Normal or low platelet count
  • High retics
  • LFT
  • indirect and direct hyperbilirubinaemia
  • mild transaminase elevation
  • hypergammaglobinaemia
  • Occasionally
  • low complement
  • positive rheumatoid factor
  • positive ANA
  • false positive VDRL

24
  • Differential diagnosis
  • TUBERCLUSIS
  • BRUCELLOSIS
  • BORRELOSIS
  • SQUENTIAL COMMON INFECTIONS
  • HODGKENS DISEASE
  • JUVENILE RHEUMATOID ARTHERITIS
  • RAT BITE FEVER
  • CAT-SCRATCH FEVER
  • IDIOPATHIC PERIODIC FEVER
  • TYPHOID FEVER
  • MYCOPLASA PNEUMONIA

25
  • COMPLICATIONS AND SEQUALAE
  • CHRONIC MALARIA SPECIALLY P. FALCIPARUM
  • Anemia
  • Deblitation
  • Massive Splenomegaly (tropical splenomegally
    syndrome)
  • MICROTHROMBOSIS AND ISCHAMIA
  • Intestinal Tract ? bleeding and diarrhea
  • Lung ? pneumonitis
  • Brain ?diffuse edema, seizures,
    encephalopathy
  • INTRAVASCULAR HAEMOLYSIS
  • hemoglobinuria ? renal failure ( black water
    fever)
  • CHRONIC P. MALARIAE
  • nephrotic syndrome

26
PREVENTION
  • SPOROZOITES ? resistant to drugs
  • CASUAL PROPHYLAXIS drugs which act on hepatic
    phase
  • SUPPRESSION drugs which act on erythrocytic
    phase
  • CHLOROQUINE safe in pregnancy
  • CHLOROQUINE RESISTENCE ALL OVER EXCEPT
  • Central America
  • Haiti
  • Panama
  • Egypt
  • Most of the middle east

27
  • IN RESISTENT-FREE AREA
  • Cholorquine 5 m/kg of base max. 300 mg
    once/week.
  • ONE WEEK BEFORE TRAVEL FOUR WEEKS
    AFTER RETURN
  • IN CHLOROQUINE RESISTENT AREA
  • Mefloquine (not if wt. is less than 15 kg)
  • Maloprim pyrimethamine Dapsone
  • Fansidar pyrimethamine Sulfdoxane
  • FOR P.VIVAX P. OVALE
  • 2 week course of primaquine phosphate
  • SCREEN FOR G6PD BEFORE PRIMAQUINE
  • INSECT REPELLENTS MOSQUITO NETTING (night)

28
  • TREATMENT
  • New drugs has been discovered in the treatment
    of Malaria .
  • They are called the (ARTEMESSININS).
  • They are derived from a Chinese plant.
  • Introduced in the market since 1996.
  • They act as internal bomb inside the Malaria
    parasite using its own hydrogen peroxide.
  • The best treatment is called ACT.
  • ACT is combination of
  • ARTEMESSININS and CHLOROQUINE.
  • Unfortunately in the markets now in many
    countries there are mal-manufactured drugs with
    poor effectiveness and possibly emerging
    resistance.

29
  • Cont. TREATMENT
  • CHLOROQUINE PHOSPHATE Drug of choice for
  • Nonresistant P.Falciparum
  • Most infections by other species
  • Course of 3 days ERADICATES THE ERYTHROCYTIC
    PHASE
  • Give orally 10m/kg (max 600mg) as initial dose
  • 5 mg/kg 6 hours, 24 hrs 48 hrs
    later
  • MEFLOQUINE
  • effective but has neuropsychiatric side
    effects
  • QUINIDINE GLUCONATE (parental)
  • 10-14 mcg/kg as a loading dose
  • then 0.02 mg/kg/min

30
  • CHLOROQUINE RESISTENCE MALARIA
  • (P.O.)
  • QUININE SULPHATE x 3 days PYRIMETHAMINE x 3
    days SULPHADIAZINE x 3 days
  • QUININE SULFATE x 3 days TETRACYCLINE x 7 days
  • (Parentral)
  • QUININE DIHYDROCHLORIDE
  • QUININE GLUCONATE

31
  • GENERAL MEASURES
  • Hydration and fever control
  • Blood and needle precautions
  • Hospitalization with
  • persistent vomiting
  • severely ill
  • Non-immune to P. Falciparum
  • Iron and folate level
  • Hepatitis and HIV screening (especially for
    drug users)

32
  • FOR CELEBRAL MALARIA
  • Rule out other causes
  • Anticonvulsants
  • Parental antimalarial
  • Control of cerebral edema
  • Disferoxamine
  • Steroids Contraindicated ( except with
    intravascular hemolysis)

33
Giardiasis
34
  • Essentials of diagnosis
  • Chronic relapsing diarrhea
  • Flatulence, bloating, anorexia, poor wt. gain
  • Absence of fever and blood in stool
  • Presence of TROPHOZOITES in diarrhe or stool
  • Cysts in formed stools

35
  • GENERAL CONSIDERATIONS
  • In many areas most common protozoan in children
  • Caused by GIARDIA INTESTINALS
  • Water Drinking (contaminated water) in endemic
    areas
  • Food-borne outbreaks do occur
  • Incidence in DAYCARE NURSERIES up to 50
  • Incidence in mental instituations
  • The parasite resides in the duodenum and jujenum
    ? Inflamation subtotal villous atrophy

36
(No Transcript)
37
Clinical findings
  • Cyst ingestion trophozoites live
    non-invasively in the small intestine
  • Symptoms develop in 1-3 weeks
  • Diarrhea (soft)
  • Steatorrhea mucus but no RBC / WBC
  • Abdominal cramps
  • anorexia, vomiting ? wt. lost
  • The illness may last days to months or my relapse

38
Laboratory findings
  • CBC normal (no eosinophils)
  • Fresh stool ve trophozoites
  • Formed stool oval cysts
  • Duodenal aspirate biopsy
  • String test (Enterotest)
  • Giardia antigen in stool

39
  • Differential diagnosis
  • Toddlers diarrhea
  • TB enteritis
  • Chronic amoebiasis
  • Other causes of steatorrhea.


  • PREVENTION
  • Avoid unclean water and food stuffs
  • Hand-washing is important
  • Animals are not vectors
  • Asymptomatic carrier ? identify and treat if
    needed

40
Treatment
  • Treat symptomatic day care center cases their
    contacts
  • Drugs
  • Furazolidine 2mg/kg X 6h X 7-10 days
  • Metronidazole 5m/kg X 8h X 5-10 days
  • Quinacrine HCL 2mg/kg X 8h X 5-10 days
  • NB. giardiasis maybe self limiting and may
    relapse

41
Leshmaniasis
42
  • General consideration
  • Caused by protozoan of the genus leishmania
  • Conveyed by female sand fly in which flagellate
    (proamistigote) develop
  • In man ? in monocytes and macrophages ?
    amastigotes (leishmann-donovan bodies)

43
  • Visceral leishmaniasis (kala azar)
  • In India ? man is the main host
  • In Mediterranean ? dogs and foxes are main
    reservoirs
  • Transmission by sandflies
  • blood transfusion
  • Multiplication by simple fission in monocytes
    macrophages in various organs ? huge
    hepatosplenomegally and lymphadenopathy
  • Lishmania ? Malnutrition and Immune Suppression
    ? Intercurrent infections
  • Tuberculosis

44
  • Clinical presentation
  • Incubation period 1-2 months up to 10 years
  • Insidious onset of fever
  • Temperature is either remittent or intermittent
  • Hepatosplenomegally
  • Lymphadenopathy
  • If untreated ? severe anemia and wasting
  • Facial hyperpigmentation
  • After therapy Dermal leshmaniasis,

  • Hypopigmentaed macules,
  • Erythematous
    macules,
  • Nodular
    eruption

45
  • Diagnosis
  • Pancytopenia bone marrow suppression
    hypersplenism
  • Immunoglobulin (esp IgG) albumin
  • Aspirated and cultures from
  • Bone marrow,
  • liver spleen,
  • lymph nodes
  • ve Serology immunoflourescene
  • C.F.T
  • Leishmania skin test ? negative
  • using killed proamstigotes

46
Differential diagnosis
  • Infective endocarditis
  • Typhoid fever
  • Brucellosis and tuberculosis
  • Lymphomas
  • Bilharizaisis
  • Malaria

47
Treatment
  • Asia (India) ? good recovery
  • Sudan east Africa ? more resistant
  • Drugs used
  • sodium stibogluconate
  • pentavalent antimony compound
  • IM or IV for 10 days,
  • could be repeated after 10 days if needed days
  • In resistant cases use
  • Pentamidine Isethionate
  • 2 hydroxy Stilbamidine
  • Amphotericin B

48
Prevention
  • In endemic areas ? destroy stray dogs and foxes
  • Sandflies should be combated by insecticides
    repellents
  • No vaccine available

49
Other types of leishmaniasis
  • Leishmania of old world LESHMANIA TROPICA
    (ORIENTAL SORE)
  • Geographical region
  • Asia, India, North Africa, Arabia
  • Vector sandfly,
  • transmits the parasite from
    animal to man (ZOONOSIS)
  • symptoms and signs
  • incubation period 2-5 weeks up to years
  • papule at the bite site (usually the face and
    limbs)
  • ulceration of the papule ? scarring

50
  • Diagnosis
  • Dry needle aspirate or skin slit smear ? ve for
    the organism
  • Positive skin test
  • Positive serology
  • Therapy
  • antimony compound reduces the scarring
  • Resistant cases pentamidine amphotericin
  • There is a vaccine for L.Tropica

51
  • Leishmania of the new world
  • Leishmania Brazilliensis ? Espundia
  • Leishmania Mexicana ? Chicleroulcer
  • Leishmania peruviana ? Uta
  • Geographical distribution south america
  • Vector sandfly

52
  • Symptoms and signs
  • Painful mucocutaneous ulcers or granulomas
  • Nasolabial lesions (common)
  • Lips, palate
  • ? terrible suffering and disfigurment
  • Diagnosis
  • skin biopsy
  • ve skin test
  • serology
  • Therapy
  • Antimony compound
  • Establishing espundia ? Amphotericin

53
Brucellosis
54
  • IT IS A ZOONOTIC DISEASE CAUSED BY SPECIES
    BRUCELLA
  • Brucella Melitensis goats and sheep
  • Brucella Abortus cattle
  • Brucella Suis swine
  • Brucella Canis dogs
  • Routes of infection in pediatrics
  • Direct contact
  • Inhalation of aerosols
  • Ingestion of raw milk or milk products from
    infected animals
  • Incidence could be decreased by
  • Control of the disease in domestic animals
  • Pasteurization of milk

55
  • Presentation in Children
  • 50 acute disease
  • Other 50 subacute disease
  • Eitiology
  • Brucella named for SIR DAVID BRUCE who first
    isolated the organism in 1887
  • Epidemiology
  • In industrialized countries ? occupational hazard
  • In USA ? pediatric cases about 10
  • In Arabia ? more

56
  • Endemic brucellosis
  • caused by ingestion or raw milk, cream, butter,
    cheese or ice cream
  • Organism my directly invade Eye, nasopharynx and
    genital tract
  • Brucella can survive up to 3 weeks in
    refregerated garcass
  • Endemic disease is maintained In Animals
    through excretion of large numbers of the
    organisms
  • in genital secretions and milk with vertical
    and horizontal transmission
  • Brucella causes ? abortion in Animals

57
  • Human to human transmission is Rare but may be
    caused by
  • Blood transmission
  • Bone marrow transplantation
  • Transplacental
  • Perinatal exposure

58
Pathology and pathogenesis
  • BRUCELLAE ? facultative intradellular parasite
  • Capable of surviving and multiplying within
    phagocytes, red blood cells and many cell lines
  • Nonspecific host factors triggered
  • Agglutinins
  • Polymorphs
  • Complements
  • ? Opsonization phagocytosis But Intracellular
    Killing Is Less Effective
  • multiplications of the organism ? induction of
    immunity

59
  • Host responds by forming
  • Specific antibodies
  • IgM appears within 1 week and comes down by 3
    months
  • IgG appears by 2-3 weeks and persists if
    untreated or partially treated
  • Others like
  • agglutinins
  • opsonins
  • precepitins
  • C.F. antibodies

60
  • Brucella Variants are
  • S. varient (smooth) more virulent
  • resist
    intraleukocyte killing
  • R. Varient (hard) less resistant
  • All species of brucella produce
  • Granuloma in the liver, spleen, l.nodes, bone
    marrow
  • Granulomoatous inflammation of gall bladder
  • Interstitial orchitis
  • Endocarditis with vegetation
  • Granuloma in myocardium
  • Involvement of brain (neruobrucellosis),
  • skin,
  • bone

61
Clinical manifestations
  • Non specific Fever,
  • Arthralgia and
    arthritis,
  • Malaise,
  • Weakness,
  • Neurobrucellosis ?
    Depression
  • Incubation period Few Days to Months
  • The interval between onset of the Symptoms and
    Diagnosis 150 days (mean of 4 weeks
  • Hepatosplenomegaly 30-40

62
  • Uncommon manifestations
  • Osteomeyelitis (non-suppurative)
  • Myocarditis
  • Endocarditis
  • Genitourinary
  • Neonatal brucellosis

63
Diagnosis
  • History
  • Examination
  • Investigations
  • CBC hemolysis,
  • pancytopenia (hypersplenism)
  • Bone marrow involvement with haemophagocytosis
    reported
  • Acute disease before treatment
  • Blood cultures ve up to 50
  • Bone marrow cultures ve up to 90
  • Serology (IgM IgG)
  • - high titred serum prozone
  • - Inhibition ? dilute with sera

64
  • Successful treatment
  • Rapid decline of IgM
  • IgG titer may persist for months or years
  • High IgG titer ? persistent infection of relapse
  • More sensitive test enzyme immuno assay
  • Tissue biopsy (liver)

65
Differential diagnosis
  • Acute brucllosis
  • Influenza
  • Typhoid fever
  • Infectious mononucleosis
  • Tuberculosis
  • Tularaemia
  • Persistent brucellosis
  • Malignant histocycosis
  • Lymphomas
  • Tuberculosis

66
  • Prevention
  • Immunization of domestic herds
  • Pasteurization of milk
  • Periodic assessment of animals (slaughtering
    infected ones)
  • Hunters should use caution in handling
    potentially infected animals

67
  • Treatment
  • Treatment of choice is TETRACYCLINE in
    combination
  • Doxycyline (orally)
  • 5 mg/kg/day max 200m/day in 2
    divided doses
  • (Plus)
  • Streptomycin (IM)
  • 30 mg/kg/day divided every 12 hours
  • OR
  • Gentamicin (IV)
  • 5 - 7.5 mg/kg/day divided every 8 hours8h

68
  • For Children
  • Trimethoprim sulfamethoxazole (orally )
  • 10 - 12 mg/kg/day (Trimethoprim)
  • (Plus)
  • Rifampacin
  • 15 - 20 mg/kg/day
  • ( Duration of treatment 3 - 6 weeks )

69
  • Delay in Diagnosis
  • High antigen load after treatment
  • JARISH - HERXHEIMER like reaction ? Treated with
    Steroids if needed

70
  • Prognosis
  • Untreated cases ? case fatality rate is 3
  • Most deaths are due to specific organ involvement
    (as Endocarditis)
  • Following treatment ? excellent prognosis
  • Delayed diagnosis ? prolonged course
  • Complete recovery may take up to 6 months
  • Re-infection is uncommon
  • Immune individuals if invadertently injected with
    the cattle vaccine ? local and mild systemic
    disease
Write a Comment
User Comments (0)
About PowerShow.com